Melatonin for the treatment of sleep
disturbances in major depressive disorder
by
Dolberg OT, Hirschmann S, Grunhaus L
Sheba Medical Center,
Ramat Gan, Israel.
otdol@main.aquanet.co.il
Am J Psychiatry 1998 Aug; 155(8):1119-21

ABSTRACT

OBJECTIVE: The authors' goal was to examine the hypnotic effects of slow-release melatonin during the initial 4 weeks of treatment with fluoxetine in 19 patients with major depressive disorder. METHOD: Twenty-four outpatients with major depressive disorder were included in the study; 19 completed the study. Ten patients were treated with fluoxetine plus slow-release melatonin and nine were given fluoxetine plus placebo in a double-blind protocol for 4 weeks. Response was assessed by using rating scales for depression and sleep. RESULTS: The 10 patients given slow-release melatonin reported significantly better scores on the Pittsburgh Sleep Quality Index than the nine patients given placebo. No significant differences in the rate of improvement in depressive symptoms were noted between the two groups. No particular side effects were noted from the combination of fluoxetine and slow-release melatonin. CONCLUSIONS: Slow-release melatonin was effective in improving the sleep of patients with major depressive disorder. Slow-release melatonin had no effect on the rate of improvement in symptoms of major depressive disorder. The authors conclude that the role of slow-release melatonin for sleep disturbances in major depressive disorder should be investigated further.

Options
Serotonin
Melatonin
Tryptophan
Light therapy
Melatonin ligands
Winter depression
Circadian rhythms
Melatonin and memory
Tryptophan plus fluoxetine
Melatonin, cortisol and mood
Melatonin deficiencies in women

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family